Google DeepMind unveils next-gen AI model for drug discovery
Google DeepMind has introduced the third iteration of its groundbreaking artificial intelligence model, AlphaFold, aimed at enhancing the efficiency and precision of drug design and disease treatment. This latest development was announced in London on May 8, marking a significant step forward in the use of AI in molecular biology. Comprehensive mapping of life’s moleculesSince its initial breakthrough in 2020, where AlphaFold utilized AI to predict protein behaviors, the tool has evolved. The current version, developed in collaboration with Isomorphic Labs—both companies under the leadership o...